M. Yu

Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study

J. Kao, C. Peng, Chi-yi Chen, 2018, Journal of gastroenterology and hepatology.

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms

Y. Karino, Yoshiyuki Suzuki, J. Toyota, 2015, Advances in Therapy.

Independent and additive interaction between polymorphisms of tumor necrosis factor α−308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B

J. Tsai, C. Dai, Zu-Yau Lin, 2017, The Kaohsiung journal of medical sciences.

Interactive effects between Lymphotoxin α +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma

J. Tsai, C. Dai, Zu-Yau Lin, 2017, The Kaohsiung journal of medical sciences.

Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma

J. Tsai, J. Jeng, M. Hsieh, 2014, Tumor Biology.